{"filing":{"accession_number":"0001731122-26-000865","cik":"0001527728","ticker":"LNAI","company_name":"Lunai Bioworks Inc.","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"e7720_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000865/e7720_8-k.htm"},"events":[{"id":11279,"run_id":9897,"accession_number":"0001731122-26-000865","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The disclosure centers on Lunai's regained compliance with Nasdaq's minimum bid price rule but explicitly details heightened delisting risk going forward. The company is now subject to a mandatory one-year Panel monitor with no cure period if it falls out of compliance again—a material change in listing status that would directly affect investor assessment. The language regarding automatic delist determination and loss of compliance flexibility signals elevated delisting risk despite the current compliance status.","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7830,"accession_number":"0001731122-26-000865","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on Lunai's regained compliance with Nasdaq's minimum bid price rule but explicitly details heightened delisting risk going forward. The company is now subject to a mandatory one-year Panel monitor with no cure period if it falls out of compliance again—a material change in listing status that would directly affect investor assessment. The language regarding automatic delist determination and loss of compliance flexibility signals elevated delisting risk despite the current compliance status.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:02:10.850148+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7830,"accession_number":"0001731122-26-000865","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on Lunai's regained compliance with Nasdaq's minimum bid price rule but explicitly details heightened delisting risk going forward. The company is now subject to a mandatory one-year Panel monitor with no cure period if it falls out of compliance again—a material change in listing status that would directly affect investor assessment. The language regarding automatic delist determination and loss of compliance flexibility signals elevated delisting risk despite the current compliance status.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:02:10.850148+00:00","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-06-16"}]}